[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN107320777A - A kind of dura mater biological sticking patch and preparation method thereof - Google Patents

A kind of dura mater biological sticking patch and preparation method thereof Download PDF

Info

Publication number
CN107320777A
CN107320777A CN201710564371.6A CN201710564371A CN107320777A CN 107320777 A CN107320777 A CN 107320777A CN 201710564371 A CN201710564371 A CN 201710564371A CN 107320777 A CN107320777 A CN 107320777A
Authority
CN
China
Prior art keywords
sticking patch
dura mater
afterwards
cleaned
ultrasonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710564371.6A
Other languages
Chinese (zh)
Inventor
葛翠兰
沈健峰
朱培明
徐永明
孟庆苓
季嘉辉
韩韦红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI BAIYI BIOLOGICAL ENGINEERING Co Ltd
Original Assignee
SHANGHAI BAIYI BIOLOGICAL ENGINEERING Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI BAIYI BIOLOGICAL ENGINEERING Co Ltd filed Critical SHANGHAI BAIYI BIOLOGICAL ENGINEERING Co Ltd
Priority to CN201710564371.6A priority Critical patent/CN107320777A/en
Publication of CN107320777A publication Critical patent/CN107320777A/en
Priority to CN201810429745.8A priority patent/CN108478870B/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3629Intestinal tissue, e.g. small intestinal submucosa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3675Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3878Nerve tissue, brain, spinal cord, nerves, dura mater
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of dura mater biological sticking patch and preparation method thereof.The dura mater biological sticking patch uses intestinal submucosa tissue for raw material, the removal immunogenic substance technique of system, lipid is removed including the use of Ethanol Treatment, take off cell using trypsase and alkaline solution treatment, handled using DNA enzymatic and remove DNA, the steps such as α Gal antigens are removed using α galactosidase treatments, can effectively remove immunogenic substance will not destroy extracellular matrix normal configuration again.When being clinically applied to dura defect repairing, cerebrospinal fluid seepage can be effectively prevented, bootable tissue is grown into, tissue growth speed is matched with sticking patch degradation speed, and immunological rejection is low, good biocompatibility.

Description

A kind of dura mater biological sticking patch and preparation method thereof
Technical field
The invention belongs to biomedical materials field, in particular it relates to a kind of biological sticking patch repaired for dura defect And preparation method thereof.
Background technology
Dura mater is protection brain(Spinal cord)Organize the important barrier together with cerebrospinal fluid seepage is prevented.Dura defect is outside nerve Section is clinically rather common, and wound, tumour erosion, inflammatory destruction, congenital disorders and operations on cranium and brain, operation on spinal cord etc. can be made Into dura defect, so cause cerebrospinal fluid seepage, subcutaneous hematocele/hydrops, otch prolong it is circuitous be not cured, intracranial infection, brain tissue bulging, The complication such as epilepsy.Thus, for a long time, by operative repair dura mater, the complete of dura mater is kept, protect brain(Spinal cord)Tissue, Prevent cerebrospinal fluid seepage, it has also become the common recognition of neurosurgery circle.Traditional dural reconstruciton material is mainly derived from autologous tissue, material Expect limited source, and the pain of making patients, artificial dura mater patching material has been widely accepted in recent years.
At present, existing a variety of artificial dura mater materials enter clinical practice both at home and abroad, are broadly divided into 3 classes:Artificial synthesized material Material, allogenic material and xenogenic biological materials.
Synthetic material, including nonabsorable synthetic material and absorbable synthetic material.Nonabsorable it is artificial synthesized Material is foreign matter forever to the host for receiving transplanting, and chronic inflammatory reaction, scar or encapsulation reaction, machinery pressure can be caused after implantation The problems such as urgent, delayed hemorrhage, art chamber infect., there is brain bad adaptability, contacted with brain tissue in absorbable synthetic material There are chronic fibrosis, the shortcomings of catabolite is easily caused inflammation and adhesion in place.
Allogenic material, including allosome human dura mater, fascia late, acellular human body corium etc..This kind of material is through a variety of Technological means processing inactivation, histocompatbility is good.But exist some insoluble problems, may such as propagate host disease, Source limitation, expensive, ethics problem, and tissue space are big, are easily caused cerebrospinal fluid seepage etc., limit its application.
Xenogenic biological materials, frequent origins have beef tendon, ox/Pigs Hearts bag, the abdomen/pleura and trees-Osima jacoti, Osima excavata of ox/pig After removing cell component and immunogenicity Deng, these animal tissues, resulting extracellular matrix components can be developed Preferable dura mater biological material for repairing, but the product of separate sources all respectively has advantage and disadvantage.
The collagem membrane extracted by beef tendon is repaired available for dura defect, the existing several such launch in the country, but such Material is used for dura mater repairing and had the disadvantage that:Degradation rate is too fast, and material has been degraded before tissue does not grow up to;Toughness is poor, It is easily broken;Adhesion is not strong enough, and cerebrospinal fluid can ooze out from the gap for sticking periphery, forms hydrops;It is applied to defect When infiltrated by tissue fluid after, it is impossible to adjustment position, it is higher to user's skill requirement.
Coming from the dura mater sticking patch product of ox/Pigs Hearts bag, ox/pig peritonaeum or pleura has mechanical strength high, and compactness is good The advantages of.But needing, through the Chemical Treatments such as epoxides or glutaraldehyde, to have the following disadvantages its process more:Have potential thin Cellular toxicity;Need to clean repeatedly before use to remove chemical residue;Degradation rate is slower, mismatches, can cause with regeneration Fibrosis, chronic inflammatory reaction and the complication such as skull or brain tissue adhesion;Quality is hard, it is impossible to pasted with the perfection of brain tissue surface Close, it is necessary to tight suture.
In xenogenic biological materials, submucous layer of small intestine (small intestinal submucosa, SIS) source Acellular matrix is one of generally acknowledged optimal tissue renovation material of academic circles at present.SIS host materials have advantages below: Good toughness, overcomes beef tendon source and extracts the inadequate shortcoming of obtained collagen film toughness;Without epoxides or glutaraldehyde cross-linking, Avoid the potential cytotoxicity of crosslinking agent;Material is soft, can be fitted with the perfection of brain tissue surface;It can induce tissue growth, group Knit growth synchronous with material degradation, absorb complete, regeneration plasticity is perfect.In addition, also contain a variety of growth factors in SIS, Suitable microenvironment can be created for regeneration, still contain these growth factors even across the SIS of de- cell processing, such as FGF-2 and TGF-β.These growth factors have important facilitation in the reparation and reconstruct of tissue, and this is other thin Extracellular matrix materials and artificial polymer's (such as collagen, chitosan, PLA and polyglycolic acid) can not compare.
SIS host materials are as a kind of preferable dura mater alternative materials, and the current domestic dura mater sticking patch with this kind of material is only There is an imported product --- the biological duramater reparation piece of U.S. Cook Biotech Incorporated productions(Commodity Name:Biodesign Surgisis).The product has occupied 10~30% biological dacron patch market in American-European countries, enters China market nearly 10 years.But Surgisis production technology(CN 102176929 B)Only carry out SDS cleaning agents, peroxide The process steps such as acetic acid, isopropanol and aqueous slkali, although consider the steps such as sterilization, degreasing, but pointedly use does not go to exempt from Epidemic disease immunogenic substance technique, result in that cell residue amount, DNA content are too high, such as the Oasis in Surgisis series of productsTM's DNA content is 0.42ng/mg(Gilbert TW, etc, Quantification of DNA in biologic scaffoldmaterials. J Surg Res 2009, 152 (1): 135–139.), and to being present in extracellular matrix In native antigen composition --- α-gal antigens also do not consider.
In recent years, preparation of some the domestic producers to SIS products has made intensive studies.Patent of invention CN 103272275 B uses inbred strais animal intestinal submucosa tissue to ensure that the stability and uniformity of different batches of product for raw material, with machine Tool vibrates removes residual DNA with supersonic oscillations technique, overcomes Biodesign Surgisis product dna residual quantities more The problem of, the DNA residual quantities of the patented product are 120 ± 15pg/g, hence it is evident that less than Biodesign Surgisis DNA residuals 250 ± 45pg/g of amount, but the de- cell of the patent and skimming processes only with low concentration aqueous slkali within a short period of time Processing, takes off cell and degreasing effect is not good enough, and the technique for being also not directed to removal α-Gal antigens.Patent of invention CN The 101366975 B and B of CN 101366979 SIS materials are employed peracetic acid disinfectant, aqueous slkali take off cell, DNA enzymatic and α- The technique of galactosidase treatments, although consider removal immunogenic substance DNA and α-Gal antigens, but it takes off cell and de- Fat technique is only the alkaline solution treatment of short time, less effective.Though processing of the B of patent of invention CN 103405811 to SIS materials So include the steps such as sterilization, trypsase, DNA enzymatic and alpha-galactoside ferment treatment, but be not directed to degreasing process.Invention is special Although the sharp B of CN 101433735 employ " Peracetic acid+ethanol " sterilization, organic solvent degreasing, " high osmotic treatment to SIS materials + trypsin treatment+acid treatment+alkali process " takes off the technique such as cell and surfactant de-sludging, but poison is used in the technique Property stronger organic solvent degreasing, if organic solvent removes not thorough, can there is the potential risk for causing tissue toxicity to be reacted;The work Trypsinase concentration is too high in skill and processing time is long, may destroy extra-cellular matrix structure;And this invented technology is simultaneously The step of being not directed to remove DNA and α-Gal antigens.
In summary, current SIS preparation process not yet has one kind intactly to consider to remove residual cell, lipid, DNA With the technique of the immunogenic substance such as α-Gal antigens, product immunogenic substance too high levels can be caused, be easily caused and implant Immunotoxicity reaction occurs afterwards.
The content of the invention
It is an object of the invention to overcome the shortcomings of existing dura mater biological sticking patch technology of preparing, there is provided one kind use SIS systems Dura mater biological sticking patch that standby, immunogenic substances content is low, can retain natural extracellular matrix three-dimensional structure and preparation method thereof.
In order to realize the purpose of the present invention, the present invention is prepared the preparation method of dura mater biological sticking patch using SIS, employed pre- Processing, sterilization, degreasing, de- cell, remove DNA, go the PROCESS FOR TREATMENTs such as α-Gal antigens, freeze-drying and sterilizing.
The preparation method of above-mentioned dura mater biological sticking patch, is comprised the following steps that:
In below step, in addition to special instruction, the ratio of SIS materials and solution is 1:5~1:20(v/v)Between.
(1)Pretreatment
Take the chitterlings tissue wash of fresh slaughtered animals clean, be placed in 0.01% ~ 0.5% acetum and soak 10 ~ 120min, go Raw meat, scrapes mucous layer, muscle layer, placenta percreta, lymph node that division removes chitterlings jejunum using physics, isolates submucosa, cut Into fragment, rinsed at least 3 times using purified water.
(2)Sterilization
The mixed aqueous solution for the ethanol that the Peracetic acid and concentration that concentration is 0.5~1.5% are 15~25%, ultrasound condition Under, 30 ~ 120min of soaking at room temperature carries out disinfection.It is cleaned by ultrasonic at least 3 times using purified water afterwards.
(3)Degreasing
Concentration is 90-100% ethanol, under ultrasound condition, soak at room temperature 0.5-12h.It is cleaned by ultrasonic afterwards using purified water At least 3 times.
(4)Cell is taken off, DNA is removed and removes α-Gal antigens
Using the mixed aqueous solution containing 0.01~0.10% trypsase and containing 0.01~0.05%EDTA, under ultrasound condition, in 36 15-40min is soaked under the conditions of ± 2 DEG C.It is cleaned by ultrasonic at least 3 times using PBS afterwards;
Using the aqueous solution of the DNA enzymes containing 0.05~10U/ml, under ultrasound condition, 15-40min is soaked under the conditions of 36 ± 2 DEG C. It is cleaned by ultrasonic at least 3 times using PBS drifts afterwards;
Using the aqueous solution of the alpha-galactosidase containing 0.05~10U/ml, under ultrasound condition, 15- is soaked under the conditions of 20-37 DEG C 40min.It is cleaned by ultrasonic at least 3 times using PBS afterwards;
Concentration is the 5- 40mM NaOH aqueous solution, under ultrasound condition, soak at room temperature 20-60min.Surpassed afterwards using PBS Sound cleaning is until neutral.
(5)Lyophilized, sterilizing
The stacking of SIS sheet materials 3~12 is added, is fixed on mould, after freeze-drying, is cut into specification needed for Clinical practice, is used PET packaging bags are packed, and finally carry out irradiation sterilization.
Compared with prior art, the present invention has following remarkable advantage and beneficial effect:
Employ the removal immunogenic substance technique of system, remove lipid including the use of Ethanol Treatment, using trypsase and Alkaline solution treatment takes off cell, is handled using DNA enzymatic and removes DNA, and the step such as α-Gal antigens is removed using alpha-galactoside ferment treatment Suddenly.Compared with existing similar products, immunogenic substances content is lower, and such as residual cell amount is not more than 1/mirror downward view(400 ×), DNA residual quantities be not more than 120pg/g, α-Gal antigens for feminine gender(Immunofluorescence assay), lipid content is not more than 0.1%, so biocompatibility is more preferable after implanting, immunological rejection is lower, and security is more preferable.
Method of enzymatically treating used in the present invention, its concentration and action time can effectively remove immunogenic substance again not It can destroy under extracellular matrix normal configuration, product ESEM and show collagenous fiber bundle structural integrity;Water preventing ability detection display Tool prevents liquid from passing through effect;Cerebrospinal fluid seepage, and implantation material can be effectively prevented when being repaired for beasle dog dura defect It is good with normal surrounding tissue compatibility.
The dura mater biological sticking patch of the present invention is made up of 3~12 layers of individual layer SIS, when being repaired for dura defect, can be carried in short term For a good compactness barrier to prevent cerebrospinal fluid seepage;It can be grown into for a long time as organization bracket induction dura mater tissue, by Gradually with one entirety of formation of dura mater tissue around, repair deficiency prevents cerebrospinal fluid seepage, while sticking patch is progressively degraded, tissue is again Life is synchronous with sticking patch degradation speed.
Brief description of the drawings
Shown in Fig. 1 is the sample drawing of the embodiment of the present invention 1.
Shown in Fig. 2 is the section HE colored graphs of the embodiment of the present invention 1.
Shown in Fig. 3 is the electron-microscope scanning figure of the embodiment of the present invention 1.
Shown in Fig. 4 is the histotomy figure for beasle dog dural repair of the embodiment of the present invention 1.
Embodiment
The present invention is further described in detail with reference to embodiments, but is not limited to this.
Embodiment 1
(1)Pretreatment
Take the chitterlings tissue wash of fresh slaughtered animals clean, be placed in 0.5% acetum immersion 30min, chitterlings and acetic acid The ratio of solution is 1:5, mucous layer, muscle layer, placenta percreta, lymph node that division removes chitterlings jejunum are scraped using physics, separation Go out submucosa, be cut into fragment, rinsed 3 times using purified water.
(2)Sterilization
Using the mixed aqueous solution containing 1.0% Peracetic acid and 15% ethanol, the ratio of SIS materials and mixed aqueous solution is 1: 10, under ultrasound condition, soaking at room temperature 100min carries out disinfection.It is cleaned by ultrasonic 3 times using purified water afterwards.
(3)Degreasing
Concentration is 95% ethanol, and the ratio of SIS materials and ethanol is 1:10, under ultrasound condition, soak at room temperature 2h.Afterwards It is cleaned by ultrasonic 3 times using water for injection.
(4)Cell is taken off, DNA is removed and removes α-Gal antigens
Using the mixed aqueous solution containing 0.02% trypsase and containing 0.02%EDTA, SIS materials and trypsase/EDTA solution Ratio be 1:5, under ultrasound condition, 30min is soaked under the conditions of 37 DEG C.It is cleaned by ultrasonic 3 times using PBS afterwards;
Using the aqueous solution of the enzymes of DNA containing 5U/ml, the ratio of SIS materials and DNA enzymatic solution is 1:5, under ultrasound condition, in 37 20min is soaked under the conditions of DEG C.It is cleaned by ultrasonic 3 times using PBS drifts afterwards;
Using the aqueous solution of the alpha-galactosidase containing 5U/ml, the ratio of SIS materials and alpha-galactoside enzyme solutions is 1:5, surpass Under the conditions of sound, 20min is soaked under the conditions of 30 DEG C.It is cleaned by ultrasonic 3 times using PBS afterwards;
Concentration is the 25mM NaOH aqueous solution, and the ratio of SIS materials and NaOH solution is 1:20, under ultrasound condition, normal temperature Soak 50min.It is cleaned by ultrasonic afterwards using PBS until neutral.
(5)Lyophilized, sterilizing
SIS materials 4 are laminated and added, are fixed on mould, is freeze-dried, is cut into 4cm × 7cm specifications, is entered using PET packaging bags Row packaging, finally carries out irradiation sterilization.Product is as shown in Figure 1.
Embodiment 2:The sample prepared to embodiment 1 carries out physical property detection, chemical property detection, histology Detection, growth factor detection, biology performance detection and animal experiment.
1. physical property is detected
1)Water preventing ability
Method:Reference《YY/T 0471.3-2004 contact Wound dressing test method third portions:Water preventing ability》Method enter Row detection.
As a result:With water preventing ability.
2)Suture strength
Method:With 3-0 non-absorbing suture in sticking patch both sides center away from being sutured at edge 2mm, by the suture other end and sample The other end be separately fixed on tensiometer two ends, stretched with 20mm/min speed, until stitch points are torn, record Maximal force.3 batches of samples are detected as stated above.
As a result:Suture strength is in 3N ~ 5N scopes.
3)Tensile strength
Method:Sample is cut to width for 10mm shapes respectively along both direction;In relative humidity 40% ~ 60%, temperature after cutting Tested after being placed 2 hours in 22 ± 2 DEG C of environment of degree.Fixture spacing is 25mm, and sample two ends are fixed on into cupping machine Chuck on, with 100mm/min speed tensile, maximal force during record fracture.3 batches of samples are carried out as stated above Detection.
As a result:Tensile strength is in 30N ~ 35N scopes.
4)Bursting strength
Method:According to《YY 0500-2004 cardiovascular implant artificial blood vessels》8.3.3.2 the measurement side for rupture strength of popping one's head in Method is chosen 9.5mm diameters probe and detected.3 batches of samples are detected as stated above.
As a result:Bursting strength is in 85N ~ 90N scopes.
2. chemical property is detected
1)Acid-base value
Method:According to《GB/T14233.1 medical infusions, blood transfusion, the part of the instrument used for injection method of inspection the 1st:Chemical analysis method》 Specified in acid-base value method carry out.
As a result:The difference of the PH values of test liquid and blank control liquid is no more than 1.5.
2)Bacterial endotoxin
Method:According to GB/T 14233.2-2005《Medical infusion, blood transfusion, the part of the instrument used for injection method of inspection the 2nd:Biology Test method》Specified in bacterial endotoxin test method carry out.
As a result:Bacteria endotoxin content is less than 2.15EU/ pieces, meets and contacts medicine equipment to bacterial endotoxin with cerebrospinal fluid The requirement of limitation.
3)DNA residual quantities
Method:According to YY/T 0606.25-2014《Animal derived biomaterial DNA determination of residual amount methods:Fluorescence colour》Enter Row detection.
As a result:DNA residual quantities are 80 ± 12 pg/g.
4)α-Gal antigenic contents
Method:After sample is fixed with paraformaldehyde, routine paraffin wax embedded section, piece is thick 3 microns.Utilize biotin labeling BSI- B4 and α-Gal antigens special affinity characteristic carry out immunohistochemical reaction.Coloration result judges:Dark brown yellow particle is strong sun Property(+++), brown yellow granule is the positive(++), yellow particle is weakly positive(+), have no and be colored as feminine gender(-).
As a result:For feminine gender(-).
5)Lipid content
Method:Reference《Fatty measure in the food of GB/T 5009.6》Middle soxhlet extraction methods are measured.
As a result:Lipid content is 0.08%.
3. histology
1)Observation by light microscope
Method:Fixed with 10% neutral formalin, FFPE, be cut into 0.4 micron of thin slice, dewaxed through dimethylbenzene, series wine Essence dehydration, haematine-eosin stains, micro- Microscopic observation cell residue situation and matrix fiber structure.
As a result:Acellular and cell fragment residual;Collagenous fibres are continuous, no fracture, as shown in Fig. 2.
2)Ultrastructural observation
Method:It is scanned using electron scanning mirror.
As a result:Material porous structure, collagenous fibres are without fracture, as shown in Fig. 3.
4. growth factor is detected
Method:The content that fibroblast growth factor is detected using ELLISA methods, concrete operations side will be used after tissue mashing Method refers to kit operation instructions.
As a result:Content is 9540-9937pg/g.
5. biology performance is detected
Method:Tested with reference to GB/T16886 series methods.
As a result:Cell-cytotoxic reaction is less than or equal to 1 grade;Without delayed allergy;Intradermal reaction shows test specimen And the difference of solvent control mean score is less than 1.0;Without pyrogenicity;Without hemolytic reaction;Genetic toxicity test result shows that mouse hinders Cold salmonella back mutation(Ames)The negative, mouse lymphoma assay of experiment is negative, the distortion of dye-free body Property;Without acute generalised toxic reaction;Without sub- chronic generalized toxicity;Muscular grafting 30 days, 60 days, 90 days with negative controls Tissue reaction without significant difference.
6. animal experiment
Method:Using Cook(COOK)The biological duramater reparation piece of biotech company's production(Registration certificate is numbered:State's food medicine prison Tool(Enter)Word 2014 the 3462661st)As control, carry out Beagal dogs dura defect using dura mater biological sticking patch and repair Art.
As a result:After implantation 3 months, implantation material and normal endocranium obscure boundary have been merged;It is implanted into material fine Dimension is substituted by cambium;Material position is implanted into normal endocranium histology and morphology structure without significant difference, it is seen that fiber is female The cells such as cell, macrophage, lymphocyte, thick liquid cell are present, it is seen that angeogenesis;Arachnoid and brain tissue are normal. The dura mater biological sticking patch cerebral dura mater repairing defect histotomy of 3 months is as shown in Figure 4.
The above embodiment of the present invention is the description of the invention and cannot be used for the limitation present invention, the right with the present invention Any change in claim suitable implication and scope, is all considered as being included within the scope of the claims.

Claims (2)

1. the invention discloses a kind of preparation method of dura mater biological sticking patch, it is characterised in that including following operating procedure:
(1)Pretreatment
Take the chitterlings tissue wash of fresh slaughtered animals clean, be placed in 0.01% ~ 0.5% acetum and soak 10 ~ 120min, go Raw meat, scrapes mucous layer, muscle layer, placenta percreta, lymph node that division removes chitterlings jejunum using physics, isolates submucosa, cut Into fragment, rinsed at least 3 times using purified water;
(2)Sterilization
The mixed aqueous solution for the ethanol that the Peracetic acid and concentration that concentration is 0.5~1.5% are 15~25%, ultrasound condition Under, 30 ~ 120min of soaking at room temperature carries out disinfection, and is cleaned by ultrasonic at least 3 times using purified water afterwards;
(3)Degreasing
Concentration is 90-100% ethanol, under ultrasound condition, and soak at room temperature 0.5-12h is cleaned by ultrasonic using purified water afterwards At least 3 times;
(4)Cell is taken off, DNA is removed and removes α-Gal antigens
Using the mixed aqueous solution containing 0.01~0.10% trypsase and containing 0.01~0.05%EDTA, under ultrasound condition, in 36 15-40min is soaked under the conditions of ± 2 DEG C, is cleaned by ultrasonic at least 3 times using PBS afterwards;
Using the aqueous solution of the DNA enzymes containing 0.05~10U/ml, under ultrasound condition, 15-40min is soaked under the conditions of 36 ± 2 DEG C, It is cleaned by ultrasonic at least 3 times using PBS drifts afterwards;
Using the aqueous solution of the alpha-galactosidase containing 0.05~10U/ml, under ultrasound condition, 15- is soaked under the conditions of 20-37 DEG C 40min, is cleaned by ultrasonic at least 3 times using PBS afterwards;
Concentration is the 5- 40mM NaOH aqueous solution, under ultrasound condition, soak at room temperature 20-60min, is surpassed afterwards using PBS Sound cleaning is until neutral;
(5)Lyophilized, sterilizing
The stacking of SIS sheet materials 3~12 is added, is fixed on mould, after freeze-drying, is cut into specification needed for Clinical practice, is used PET packaging bags are packed, and finally carry out irradiation sterilization.
2. a kind of preparation method of dura mater biological sticking patch according to claim 1, it is characterised in that:The step (1)、(2)、(3)、(4)The ratio of middle material and solution is 1:5~1:20(v/v)Between.
CN201710564371.6A 2017-07-12 2017-07-12 A kind of dura mater biological sticking patch and preparation method thereof Pending CN107320777A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201710564371.6A CN107320777A (en) 2017-07-12 2017-07-12 A kind of dura mater biological sticking patch and preparation method thereof
CN201810429745.8A CN108478870B (en) 2017-07-12 2018-05-08 Dura mater biological patch and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710564371.6A CN107320777A (en) 2017-07-12 2017-07-12 A kind of dura mater biological sticking patch and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107320777A true CN107320777A (en) 2017-11-07

Family

ID=60197387

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710564371.6A Pending CN107320777A (en) 2017-07-12 2017-07-12 A kind of dura mater biological sticking patch and preparation method thereof
CN201810429745.8A Active CN108478870B (en) 2017-07-12 2018-05-08 Dura mater biological patch and preparation method thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201810429745.8A Active CN108478870B (en) 2017-07-12 2018-05-08 Dura mater biological patch and preparation method thereof

Country Status (1)

Country Link
CN (2) CN107320777A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107737373A (en) * 2017-12-07 2018-02-27 山东隽秀生物科技股份有限公司 A kind of preparation method of tendon repair material
CN108324990A (en) * 2018-02-11 2018-07-27 温州优墨生物科技有限公司 A kind of method bone material cell free method and prepare Acellular bone powder
CN108785746A (en) * 2018-07-05 2018-11-13 承功(厦门)生物科技有限公司 A kind of de- cell trees-Osima jacoti, Osima excavata fast preparation method
CN109125922A (en) * 2018-08-14 2019-01-04 上海白衣缘生物工程有限公司 A kind of biology covers the application in terms of nerve stimulator implantation
CN109125812A (en) * 2018-08-22 2019-01-04 上海白衣缘生物工程有限公司 A kind of composite membrane and preparation method thereof for Guided Bone Regeneration
CN109364299A (en) * 2018-11-28 2019-02-22 上海白衣缘生物工程有限公司 A kind of basin bottom Biological Repair mesh sheet and preparation method thereof
CN109453428A (en) * 2018-11-28 2019-03-12 上海白衣缘生物工程有限公司 A kind of rotator cuff Biological Repair mesh sheet and application thereof and preparation method
CN111202081A (en) * 2020-01-15 2020-05-29 四川大学 A kind of sterilization method of drying collagen-based biological material
CN113332494A (en) * 2020-05-26 2021-09-03 山东隽秀生物科技股份有限公司 High-strength extracellular matrix sponge and preparation method and application thereof
CN113425904A (en) * 2020-03-23 2021-09-24 成都中科奥格生物科技有限公司 Oral cavity patch material and preparation method and application thereof
WO2023115912A1 (en) * 2021-12-24 2023-06-29 杭州华迈医疗科技有限公司 Preparation method for decellularized matrix biomaterial
CN118059313A (en) * 2024-01-19 2024-05-24 爱博睿美(成都)医疗科技有限公司 Acellular matrix biological patch for cornea repair and preparation method and application thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109248339A (en) * 2018-11-28 2019-01-22 上海白衣缘生物工程有限公司 A kind of hernia Biological Repair mesh sheet and preparation method thereof
CN110960731A (en) * 2019-12-12 2020-04-07 成都奇璞生物科技有限公司 Preparation method of medical surgical biological patch
CN112675364A (en) * 2021-01-05 2021-04-20 宁波瑞瑧生物科技有限公司 Composite guided tissue regeneration membrane and preparation method thereof
CN113368313B (en) * 2021-06-10 2022-06-03 吾奇生物医疗科技(江苏)有限公司 Preparation method of biological membrane, product and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010003853A (en) * 1999-06-25 2001-01-15 박호군 Vaccine compositions using antigens encapsulated within alginate microspheres for oral administration and preparation process thereof
CN101366975B (en) * 2008-09-03 2011-07-20 陕西瑞盛生物科技有限公司 Preparation method for cellfree intestinum tenue submucosa biological material
CN102462561A (en) * 2010-11-19 2012-05-23 北京迈迪顶峰医疗科技有限公司 Small intestinal submucosa (SIS) soft tissue repair patch and preparation method thereof
CN103251987B (en) * 2013-04-07 2014-12-31 陕西佰傲再生医学有限公司 Acellular biological patch, preparation method and apparatus thereof

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107737373A (en) * 2017-12-07 2018-02-27 山东隽秀生物科技股份有限公司 A kind of preparation method of tendon repair material
CN108324990A (en) * 2018-02-11 2018-07-27 温州优墨生物科技有限公司 A kind of method bone material cell free method and prepare Acellular bone powder
CN108785746B (en) * 2018-07-05 2021-05-04 承功(厦门)生物科技有限公司 Method for rapidly preparing decellularized pig small intestine submucosa
CN108785746A (en) * 2018-07-05 2018-11-13 承功(厦门)生物科技有限公司 A kind of de- cell trees-Osima jacoti, Osima excavata fast preparation method
CN109125922A (en) * 2018-08-14 2019-01-04 上海白衣缘生物工程有限公司 A kind of biology covers the application in terms of nerve stimulator implantation
CN109125812A (en) * 2018-08-22 2019-01-04 上海白衣缘生物工程有限公司 A kind of composite membrane and preparation method thereof for Guided Bone Regeneration
CN109453428A (en) * 2018-11-28 2019-03-12 上海白衣缘生物工程有限公司 A kind of rotator cuff Biological Repair mesh sheet and application thereof and preparation method
CN109364299A (en) * 2018-11-28 2019-02-22 上海白衣缘生物工程有限公司 A kind of basin bottom Biological Repair mesh sheet and preparation method thereof
CN109364299B (en) * 2018-11-28 2021-06-01 上海白衣缘生物工程有限公司 Biological pelvic floor repairing mesh and preparation method thereof
CN111202081A (en) * 2020-01-15 2020-05-29 四川大学 A kind of sterilization method of drying collagen-based biological material
CN111202081B (en) * 2020-01-15 2021-09-21 四川大学 Sterilization method of dry collagen-based biological material
CN113425904A (en) * 2020-03-23 2021-09-24 成都中科奥格生物科技有限公司 Oral cavity patch material and preparation method and application thereof
CN113332494A (en) * 2020-05-26 2021-09-03 山东隽秀生物科技股份有限公司 High-strength extracellular matrix sponge and preparation method and application thereof
CN113332494B (en) * 2020-05-26 2022-11-25 山东隽秀生物科技股份有限公司 High-strength extracellular matrix sponge and preparation method and application thereof
WO2023115912A1 (en) * 2021-12-24 2023-06-29 杭州华迈医疗科技有限公司 Preparation method for decellularized matrix biomaterial
CN118059313A (en) * 2024-01-19 2024-05-24 爱博睿美(成都)医疗科技有限公司 Acellular matrix biological patch for cornea repair and preparation method and application thereof
CN118059313B (en) * 2024-01-19 2024-08-16 爱博睿美(成都)医疗科技有限公司 Acellular matrix biological patch for cornea repair and preparation method and application thereof

Also Published As

Publication number Publication date
CN108478870A (en) 2018-09-04
CN108478870B (en) 2020-03-06

Similar Documents

Publication Publication Date Title
CN107320777A (en) A kind of dura mater biological sticking patch and preparation method thereof
CN109453428B (en) Rotator cuff biological repair net sheet and application and preparation method thereof
CN107007886B (en) A kind of biological tissue's host material, preparation method and its usage
US9642937B2 (en) Preparation method for implantable medical biological materials of animal origin
CN106983918B (en) Biological anti-adhesion material, preparation method and application thereof
CA2634351C (en) A biological artificial nerve guide comprising a tissue membrane with a spiral support and method of making
US8518436B2 (en) Engineered extracellular matrices
US11529437B2 (en) Biological tissue matrix material, preparation method therefor and use thereof in otological repair material
CN103272274B (en) Biological repair tablet for herniae and preparation method thereof
CN107050520A (en) Compound bio sticking patch and preparation method thereof
CN105963787B (en) The preparation method of biological sticking patch
CN109248339A (en) A kind of hernia Biological Repair mesh sheet and preparation method thereof
JP2004529711A (en) Submucosal xenograft
CN107007882B (en) Nerve repair material, preparation method and application
CN106474548B (en) Biological induction type artificial dura mater and preparation method thereof
CN104130437A (en) Dural/spinal dural biological patch material, preparation method and application thereof
CN109125812A (en) A kind of composite membrane and preparation method thereof for Guided Bone Regeneration
CN109364299B (en) Biological pelvic floor repairing mesh and preparation method thereof
CN107050515B (en) Corneal stroma, preparation method and application
CN103272275B (en) Biological repair tablet for endocranium and preparation method thereof
CN103301507A (en) Artificial biological tendon and preparation method thereof
CN210698333U (en) Biological mesh for repairing soft tissue
CN107080861B (en) High-induction-activity repair material, preparation method and application
CN109498840B (en) Eye surface repairing film and preparation method thereof
CN109498841A (en) A kind of bion periosteum repair materials and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171107

WD01 Invention patent application deemed withdrawn after publication